Zealand Pharma’s petrelintide delivers double-digit weight loss in next-gen obesity treatment

The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity

Novo Nordisk’s CagriSema delivers strong Phase 3 results across REIMAGINE diabetes trials

Agilus’s Idylla claims to deliver cancer mutation results in just 3 hours

Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology

Lilly’s “triple agonist” drug delivers striking weight loss & broad health gains in late-stage trials

Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems

Smile Foundation delivers 20 lakh healthcare treatments in FY26

Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006

STRIDE-based regimens show survival momentum in EMERALD-3 liver cancer trial

While overall survival data remain immature, the results pointed to a favourable trend.

Zydus’ Saroglitazar wins FDA priority review after strong Phase 3 results in liver disease trial

The therapy also delivered significant improvements in key liver enzyme markers

Pfizer's LORBRENA delivers landmark seven-year survival results in advanced lung cancer trial

The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer

Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz

The company highlighted continued demand strength and pricing resilience despite global disruptions

Sun's cancer drug shines delivering 50% response rate with long-lasting tumor control

These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC